Immunocore

Immunocore

Primary Menu

  • About us
    • Management Team
    • Board of Directors
    • Partners
  • Our science
    • Pipeline
    • Publications
    • Scientific Advisory Board
  • Our therapy areas
    • Oncology
    • Infectious Diseases
    • Autoimmune and Inflammation Diseases
  • For patients
  • News
  • Contact us
  • Careers

Primary Menu

  • About us
  • Our science
  • Our therapy areas
  • For patients
  • News
  • Contact us
  • Careers
  1. Home
  2. /
  3. News

News

  • 8 February 2018

    Immunocore Announces Leadership Change
  • 4 January 2018

    Immunocore Strengthens its Board with Appointments of Laura Wade-Gery and Kristine Peterson as Non-Executive Directors
  • 11 December 2017

    Immunocore’s IMCgp100 Receives Promising Innovative Medicine (PIM) Designation Under UK Early Access to Medicines Scheme (EAMS) for the Treatment of Patients with Uveal Melanoma
  • 13 November 2017

    Immunocore Presents Single Agent IMCgp100 data in Metastatic Uveal Melanoma Showing Durability, Doubling in One-Year Overall Survival Rate
  • 31 October 2017

    Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
  • 4 October 2017

    Immunocore Appoints Andrew Hotchkiss as Chief Commercial Officer
  • 18 September 2017

    Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases
  • 7 July 2017

    Immunocore and MEPC announce significant laboratory expansion at Milton Park in Oxfordshire, UK
  • 3 July 2017

    Immunocore Announces Third Oncology Target Selected in Discovery Collaboration with GlaxoSmithKline
  • 5 June 2017

    Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting
  • ← Previous
  • 1
  • 2
  • 3
  • 4 (current)
  • 5
  • 6
  • 7
  • …
  • 11
  • Next →

Sign up to receive news email alerts

News archive
  • Show all
  • 2021 (1)
  • 2020 (8)
  • 2019 (13)
  • 2018 (10)
  • 2017 (13)
  • 2016 (11)
  • 2015 (20)
  • 2014 (6)
  • 2013 (11)
  • 2012 (3)
  • 2011 (1)
  • 2010 (4)
  • 2009 (1)
  • 2008 (1)

Immunocore

Immunocore
  • About us
  • Our science
  • Our therapy areas
  • For patients
  • News
  • Contact us
  • Privacy and Social Media Guidelines
  • Cookies
  • Payments and Disclosures
  • Clinical trials

©2021 Immunocore, Ltd. All rights reserved. ImmTAC, ImmTAV, ImmTAB, ImmTAAI and ImmTAX are all registered trademarks of Immunocore, Ltd